Company intelligence / Profile preview

Enzene Biosciences

Pune, Maharashtra, Indiaenzene.com ↗

Ownership: Private
Employees: ~500
Development stage: Commercial

Overview

Enzene has commercialized seven biosimilars in under three years. Its pipeline spans pre-clinical to late-stage development. The company’s proprietary platform enables cost-effective and scalable biologics production. Clinical results are not detailed publicly but the company claims successful launches and robust global expansion

Therapeutic areas: OphthalmologyEndocrinologyImmunologyHematologyOncology
Modalities: Monoclonal antibodyRecombinant proteinRecombinant enzymeConjugated proteinBispecific monoclonal antibodyFusion proteinSynthetic peptidePlasmid DNA (pDNA)Phytopharmaceuticals
Industry: Biotech

Partnerships

Alkem LaboratoriesOutlicensing partners globally

Beyond the preview

Go deeper on Enzene Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enzene Biosciences.

Explore the full profile